It is with our greatest pleasure to welcome you to the inaugural issue of VIEW, a new journal that focuses on biodiagnostics. This new journal is co-published by Wiley and Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM), China. Why the journal was named VIEW? We have been asked by many and here is the answer: Seeing is believing. VIEW represents the most fundamental aspects in the field of experimental medicine to visualize human health, and here are a dozen views about these aspects until you know the answer. VIEW will embrace all significant advances on experimental medicine, lab-on-a-chip, microfluidics, bioimaging, biomarkers, omics, biosensors and bioelectronics, drug delivery, computational diagnostics, bioinformatics, and novel diagnostic devices, etc. VIEW will endeavor to assist researchers, industry, government, academia, and community players to keep abreast of new developments in their specialist fields and to find solutions. VIEW aims to be a high-quality, interdisciplinary, and rapid-publication journal focused on “biodiagnostics” in the field of biomaterials, from in vitro to in vivo, small to mega, fundamentals to application, with particular emphasis on the biomaterials used in biotechnology and medicine. As a new journal in the biodiagnostics field, VIEW will be operated in obedience to the highest standard running by the publishing team of Wiley. Our readers will have the opportunities to discover the most interesting and important research in our regular Research Articles and Rapid Communications, insightful and discerning Reviews, Mini-reviews and Perspectives, rare Case Reports, and incisive Analysis. We would like to thank many people who have combined their effort in this very first issue of VIEW, especially our highly distinguished Editorial Board (https://onlinelibrary.wiley.com/page/journal/2688268x/homepage/editorial-board) who has been instrumental in bringing this journal to fruition by advising us with its publishing expertise and also bringing its excellent research. With the full support from Wiley's professional publishing team—Dr. Jose Oliveira, Dr. Guangchen Xu, Dr. Daping Zhang, and Dr. Tina Wang whose dedication has led VIEW toward the right direction, we are ready to embrace the challenges and excitements. In this issue, we are delighted to present Prof. Haibo Song's (Editor-in-Chief of VIEW) overview of the industry of in vitro diagnostics in China1; Prof. Chwee Teck Lim's (National University of Singapore, Singapore) insights on the future of health diagnostics2; Prof. Tiangang Liu's (Wuhan University, China) perspective on promising methods for detection of novel coronavirus SARS-CoV-23; Prof. Zhiyong Qian’s (Sichuan University, China) review of application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia4; Prof. Chunru Wang’s (Institute of Chemistry, Chinese Academy of Sciences, China) review on the potential biomedical platforms based on the functionalized Gd@C82 nanomaterials5; and Prof. Amy Shen’s (Okinawa Institute of Science and Technology (OIST), Japan) most recent research of proof-of-concept modular fluid handling prototype integrated with microfluidic biochemical assay modules for point-of-care testing.6 We sincerely thank them for their fine contributions to this issue, and we believe our readers will enjoy reading these articles! Manuscripts can be submitted online through SholarOne Manuscripts (https://mc.manuscriptcentral.com/viw2). All papers will be published online as soon as they are accepted and will be fully citable. In addition, there are no article publication charges for the first three publication years of VIEW. We hope that you enjoy reading this first issue of VIEW, and you will consider this journal as one of your favorites to submit your next excellent manuscript. VIEW is on its way to facilitate researchers changing the world, visualizing human health and illuminating wellness. We look forward to receiving your outstanding manuscripts. Prof. Haibo Song Editor-in-Chief, VIEW China Association of In Vitro Diagnostics, China Prof. Hualiang Wang Executive Editor-in-Chief, VIEW Professional Community of Experimental Medicine, China Dr. Jing Zhu Consulting Editor, VIEW